3D Cell Culture Market to Surpass US$ 11,335.1 Million by 2027 - Coherent Market Insights

Global 3D Cell Culture Market by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - is estimated to be valued at US$ 2,604.3 Mn in 2020 and is expected to exhibit a CAGR of 23.4% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The rising prevalence of cancer and infectious diseases are expected to propel growth of the global 3D cell culture market over the forecast period. The rising demand for 3D cell culture for treatment of various diseases, owing to increasing prevalence of cancer and infectious diseases is expected to boost the 3D cell culture market growth over the forecast period.

For instance, according to the World Health Organization (WHO): September 2018 data finding, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths globally in 2018. Furthermore, according to the same source, globally, about one in six deaths occur due to cancer.

In addition, according to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths were reported in the U.S.

Global 3D Cell Culture Market– Impact of Coronavirus (COVID-19) Pandemic

3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. Stem cells are emerging as a favored model to predict what type of cell can be permissive to certain types of viruses, giving insight to scientists and clinicians alike and offering advantages over the limited resources of biobanks for human tissue, in vitro Petri dish cultures or animal models. Several companies are supporting the research and development activities using 3D cell cultures for development of new screening and therapy platforms. For instance, in January 2021, Corning Incorporated highlighted its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery as new solutions to support evolving industry needs such as COVID-19 response, disease models, and drug discovery at this year's 2021 virtual Society for Laboratory Automation and Screening (SLAS) conference. Moreover, in November 2020, Biogelx is aiming to provide UK-Spanish research groups working on COVID-19 vaccines with advanced 3D cell culture to mitigate risk arising during drug development and testing processes. Biogelx is committed to supporting the scientific community working on COVID-19 vaccines research. In October 2020, a study published in Cell Press Journal, reported that a team of scientists from the U.K. and South Korea turned to organoids—'miniorgans' grown in three dimensions to mimic the behavior of tissue and organs. The scientists were able to grow self-organizing alveolar-like 3D structures that mimic the behavior of key lung tissue for understanding how the COVID-19 affects the lungs. The mini-lungs grown from tissue donated to Cambridge hospitals have provided a team of scientists with important insights into how COVID-19 damages the lungs. In new work, the researchers explained the mechanisms underlying SARS-CoV-2 infection and the early innate immune response in the lungs.

Browse 34 Market Data Tables and 36 Figures spread through 172 Pages and in-depth TOC on “Global 3D Cell Culture Market”- Forecast to 2027, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

https://www.coherentmarketinsights.com/market-insight/3d-cell-culture-market-534

Moreover, key players in the market are focusing on adopting inorganic growth strategies such as partnerships, in order to enhance their market share and is also expected to aid in growth of the global 3D cell culture market over the forecast period. For instance, in June 2020, Lonza Group entered into a partnership with the Sweden-based company, CELLINKto offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.

Key Takeaways of the Global 3D Cell Culture Market:

• The global 3D cell culture market is expected to exhibit a CAGR of 23.4% during the forecast period due to increasing products approvals and launches is expected to boost growth of the market. For instance, in January 2019, Visikol, a 3D cell culture characterization and analysis company, announced the launched OpenLiver 3D cell culture models to accelerate drug discovery. Visikol expanded its service offering through the introduction of its own liver 3D cell culture models.
• Among application, drug discovery segment is estimated to exhibit higher CAGR in the global 3D cell culture market over the forecast period. Ongoing research in the development of different types of 3D cell culture to assist drug development is expected to foster growth of this segment. For instance, according to data published by Syracuse University in March 2018, Professor Zhen Ma and his research team developed a process that combines biomaterials-based cell patterning and stem cell technology to make a 3D tissue model that could mimic early stage human heart development. This heart could be used for testing the effects of drugs on the human heart, prior to the clinical trials or during the clinical trials.
• Among end user, biopharmaceutical industry segment is estimated to hold largest market share in the global 3D cell culture market over the forecast period. Due to high benefits of the 3D cell cultures in the biopharmaceutical industry, companies are focusing on service launches, to provide 3D cell culture procedures to customers present in the biopharmaceutical industry. For instance, in March 2019, Lonza launched Custom Cell Biology Services for pharmaceutical companies and contract manufacturing organizations. Lonza provides services such as cell-line expansion and banking, media production, cell isolation, cell characterization, transfection services, and 3-dimensional cell-culture services.
• On the basis of region, Asia Pacific is estimated to exhibit higher CAGR in global 3D cell culture market over the forecast period. The market in Asia Pacific is expected to witness significant growth, owing to increasing healthcare expenditure. For instance, according to the Ministry of Health, Labour and Welfare, Japan spent an estimated US$ 3,054 million per capita on healthcare in 2018, which is US$ 35.50 million more than the previous year.
• Major players operating in the global 3D cell culture market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.